Work

Phase II study of the anti-ganglioside GD3 mouse/human chimeric antibody KW2871 combined with high dose interferon-a2b in patients with metastatic melanoma.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.8547

Authors: Stergios J. Moschos, Ahmad A. Tarhini, Thomas Gajewski, Andrew Mark Scott, Yan Lin, Janice Shipe-Spotloe, Weiping Xu Deblasio, Cindy Sander, Karen Matijevich, Fiona Elizabeth Smyth, Zhanqi Liu, Eric W. Hoffman, Ralph Rudolph Venhaus, Linda S. Pan, Sinhan Tran, James Fiore, John M. Kirkwood

Institutions: University of Pittsburgh Medical Center, University of Chicago, Ludwig Cancer Research, UPMC Hillman Cancer Center, University of Chicago Medical Center, Ludwig Cancer Research

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2607075701

Cites:

Cited by: 1

Related to: 10